Tratamiento de la úlcera gástrica con sucralfato y famotidina / Treatment of gastric ulcer: sucralfate vs famotidine
Rev. méd. Chile
; 119(1): 45-9, ene. 1991. tab
Article
em Es
| LILACS
| ID: lil-98181
Biblioteca responsável:
CL1.1
ABSTRACT
We conducted a double blind random study on 79 patients with gastric ulcer 39 received sucralfate, 1 g 4 times a day (Group 1) and 40 received a single evening dose of famotidine, 40 mg (Group 2). At 4 weeks, endoscopy revealed healing of the ulcer in 46% of patients in Group1 and 40% in group 2 (NS). At 8 weeks, corresponding figures were 90% and 75 (NS). All patients were able to complete treatment and minor side effects were reported from all patients, 36% with sucralfate and 28% with famotidine. Thus, sucralfate and famotidine are equally effective for therapy of gastric ulcer. The higher percentage of helaing with sucralfate observed in this study was not statistically significant
Buscar no Google
Coleções:
01-internacional
Base de dados:
LILACS
Assunto principal:
Úlcera Gástrica
/
Sucralfato
/
Famotidina
Tipo de estudo:
Clinical_trials
Limite:
Female
/
Humans
/
Male
Idioma:
Es
Revista:
Rev. méd. Chile
Assunto da revista:
MEDICINA
Ano de publicação:
1991
Tipo de documento:
Article
País de publicação:
Chile